{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:45:01Z","timestamp":1791755101071,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thiamine metabolism dysfunction syndrome 5 (THMD5) is a rare inherited metabolic disorder due to thiamine pyrophosphokinase 1(TPK1) deficiency, caused by mutations in <jats:italic>TPK1<\/jats:italic>. The core symptoms of the disease is acute or subacute onset encephalopathy, ataxia, muscle hypotonia, and regression of developmental milestones in early infancy, repeatedly triggered by acute infectious illness. However, we report two brothers of THMD5 with compound heterozygous for the mutations c.614-1G\u2009&gt;\u2009A,c.224\u2009T\u2009&gt;\u2009A p.(Ile75Asn), but the prognosis is quite different if thiamine suppled. According to our current knowledge, the missense variant c.224\u2009T\u2009&gt;\u2009A p.(Ile75Asn) was not published previously.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we describe two affected siblings in a Chinese family, after an uneventful pregnancy to non-consanguineous and healthy parents. The older brother presented with normal development during the first 6\u2009months of life, but developed regression of developmental milestones after, accompanied with muscle hypotonia, and chronic encephalopathy, and died at 1\u2009year and 6\u2009months old. The younger brother presented with acute onset encephalopathy, ataxia, muscle hypotonia, repeatedly triggered by acute infectious illness. He was compound heterozygous for the mutations c.614-1G\u2009&gt;\u2009A,c.224\u2009T\u2009&gt;\u2009A p.(Ile75Asn) identified by whole exome sequencing. He was diagnosed of THMD5 when he was 11\u2009month. Oral supplementation of thiamine 100\u2009mg\/day, the symptoms gradually disappeared. At the age of 2\u2009years and 4\u2009months, he stoped thiamine, his symptoms returned and were once again relieved by oral supplementation of thiamine 100\u2009mg\/day.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>THMD5 is a rare, but treatable neurodegenerative disease, the clinical phenotype ranges from mild to severe. Massive-dose of thiamine supplementation may ameliorate the course of TPK1 deficiency. When similar clinical cases appear, gene detection is particularly important, which is conducive to early diagnosis. Treatment with thiamine while awaiting the outcome of diagnostic tests may be a good choice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02887-9","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:03:18Z","timestamp":1664434998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaoyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoshi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-6094","authenticated-orcid":false,"given":"Jianmin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"issue":"4","key":"2887_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jimd.12125","volume":"42","author":"A Marc\u00e9-Grau","year":"2019","unstructured":"Marc\u00e9-Grau A, Mart\u00ed-S\u00e1nchez L, Baide-Mairena H, et al. Genetic defects of thiamine transport and metabolism: a review of clinical phenotypes, genetics, and functional studies. J Inherit Metab Dis. 2019;42(4):581\u201397. https:\/\/doi.org\/10.1002\/jimd.12125.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"2887_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.ajhg.2011.11.007","volume":"89","author":"JA Mayr","year":"2011","unstructured":"Mayr JA, Freisinger P, Schlachter K, et al. Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet. 2011;89(6):806\u201312. https:\/\/doi.org\/10.1016\/j.ajhg.2011.11.007.","journal-title":"Am J Hum Genet"},{"issue":"04","key":"2887_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10545-014-9712-9","volume":"37","author":"G Brown","year":"2014","unstructured":"Brown G. Defects of thiamine transport and metabolism. J Inherit Metab Dis. 2014;37(04):577\u201385. https:\/\/doi.org\/10.1007\/s10545-014-9712-9.","journal-title":"J Inherit Metab Dis"},{"issue":"03","key":"2887_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24998","volume":"82","author":"JD Ortigoza-Escobar","year":"2017","unstructured":"Ortigoza-Escobar JD, Alfadhel M, Molero-Luis M, et al. Thiamine deficiency in childhood with attention to genetic causes: survival and outcome predictors. Ann Neurol. 2017;82(03):317\u201330. https:\/\/doi.org\/10.1002\/ana.24998.","journal-title":"Ann Neurol"},{"issue":"10","key":"2887_CR5","doi-asserted-by":"publisher","first-page":"104003","DOI":"10.1016\/j.ejmg.2020.104003","volume":"63","author":"D Li","year":"2020","unstructured":"Li D, Song J, Li X, et al. Eleven novel mutations and clinical characteristics in seven Chinese patients with thiamine metabolism dysfunction syndrome. Eur J Med Genet. 2020;63(10):104003. https:\/\/doi.org\/10.1016\/j.ejmg.2020.104003.","journal-title":"Eur J Med Genet"},{"key":"2887_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jns.2017.02.063","volume":"376","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Sidiropoulos C. TPK1 mutation induced childhood onset idiopathic generalized dystonia: report of a rare mutation and effect of deep brain stimulation. J Neurol Sci. 2017;376:42\u20133. https:\/\/doi.org\/10.1016\/j.jns.2017.02.063.","journal-title":"J Neurol Sci"},{"issue":"4","key":"2887_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2014.09.010","volume":"113","author":"S Banka","year":"2014","unstructured":"Banka S, de Goede C, Yue WW, et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab. 2014;113(4):301\u20136. https:\/\/doi.org\/10.1016\/j.ymgme.2014.09.010.","journal-title":"Mol Genet Metab"},{"key":"2887_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymgmr.2013.12.007","volume":"1","author":"JL Fraser","year":"2014","unstructured":"Fraser JL, Vanderver A, Yang S, et al. Thiamine pyrophosphokinase deficiency causes a Leigh disease like phenotype in a sibling pair: identification through whole exome sequencing and management strategies. Mol Genet Metab Rep. 2014;1:66\u201370. https:\/\/doi.org\/10.1016\/j.ymgmr.2013.12.007.","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"2887_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00438-018-1517-3","volume":"294","author":"W Huang","year":"2018","unstructured":"Huang W, Qin J, Liu D, et al. Reduced thiamine binding is a novel mechanism for TPK deficiency disorder. Mol Genet Genomics. 2018;294(2):409\u201316. https:\/\/doi.org\/10.1007\/s00438-018-1517-3.","journal-title":"Mol Genet Genomics"},{"issue":"3","key":"2887_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/jpem-2018-0363","volume":"32","author":"L Zhu","year":"2019","unstructured":"Zhu L, Ruijuan W, Ye Z, et al. Identification of two novel TPK1 gene mutations in a Chinese patient with thiamine pyrophosphokinase deficiency undergoing whole exome sequencing. J Pediatr Endocrinol Metab. 2019;32(3):295\u2013300. https:\/\/doi.org\/10.1515\/jpem-2018-0363.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2887_CR11","doi-asserted-by":"publisher","first-page":"103898","DOI":"10.1016\/j.ejmg.2020.103898","volume":"63","author":"C Hu","year":"2020","unstructured":"Hu C, Li X, Zhao L, et al. Clinical and molecular characterization of pediatric mitochondrial disorders in south of China. Eur J Med Genet. 2020;63(8):103898. https:\/\/doi.org\/10.1016\/j.ejmg.2020.103898.","journal-title":"Eur J Med Genet"},{"issue":"2","key":"2887_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-0040-1715628","volume":"52","author":"CT R\u00fcsch","year":"2021","unstructured":"R\u00fcsch CT, Wortmann SB, Kovacs-Nagy R, et al. Thiamine Pyrophosphokinase deficiency due to mutations in the TPK1 gene: a rare, , Treatable Neurodegenerative Disorder. Neuropediatrics. 2021;52(2):126\u201332. https:\/\/doi.org\/10.1055\/s-0040-1715628.","journal-title":"Neuropediatrics"},{"issue":"2","key":"2887_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0040-1715631","volume":"52","author":"M Eckenweiler","year":"2021","unstructured":"Eckenweiler M, Mayr JA, Gr\u00fcnert S, et al. Thiamine treatment and favorable outcome in an infant with Biallelic TPK1 variants. Neuropediatrics. 2021;52(2):123\u20135. https:\/\/doi.org\/10.1055\/s-0040-1715631.","journal-title":"Neuropediatrics."},{"issue":"8","key":"2887_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s12031-020-01568-x","volume":"70","author":"B Zhu","year":"2020","unstructured":"Zhu B, Wu J, Chen G, et al. Whole exome sequencing identifies a novel mutation of TPK1 in a Chinese family with recurrent Ataxia. J Mol Neurosci. 2020;70(8):1237\u201343. https:\/\/doi.org\/10.1007\/s12031-020-01568-x.","journal-title":"J Mol Neurosci"},{"issue":"3","key":"2887_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24998","volume":"82","author":"JD Ortigoza-Escobar","year":"2017","unstructured":"Ortigoza-Escobar JD, Alfadhel M, Molero-Luis M, et al. Thiamine deficiency study group. Thiamine deficiency in childhood with attention to genetic causes: survival and outcome predictors. Ann Neurol. 2017;82(3):317\u201330. https:\/\/doi.org\/10.1002\/ana.24998.","journal-title":"Ann Neurol"},{"issue":"8","key":"2887_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1212\/WNL.0000000000004270","volume":"89","author":"F Invernizzi","year":"2017","unstructured":"Invernizzi F, Panteghini C, Chiapparini L, et al. Thiamine-responsive disease due to mutation of tpk1: importance of avoiding misdiagnosis. Neurology. 2017;89(8):870\u20131. https:\/\/doi.org\/10.1212\/WNL.0000000000004270.","journal-title":"Neurology."},{"key":"2887_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cca.2019.07.034","volume":"499","author":"WL Nyhan","year":"2019","unstructured":"Nyhan WL, McGowan K, Barshop BA. Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia disease. Clin Chim Acta. 2019;499:13\u20135. https:\/\/doi.org\/10.1016\/j.cca.2019.07.034.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"2887_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/jcm8070991","volume":"8","author":"E Bugiardini","year":"2019","unstructured":"Bugiardini E, Pope S, Feichtinger RG, et al. Utility of whole blood thiamine pyrophosphate evaluation in TPK1-related diseases. J Clin Med. 2019;8(7):991. https:\/\/doi.org\/10.3390\/jcm8070991.","journal-title":"J Clin Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02887-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T07:05:49Z","timestamp":1664435149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2887"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02887-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the children\u2019s guardian and other individuals in the family tree, and approval for this study was provided by the Research Ethics Committee of Children\u2019s Hospital of Jiangxi Province.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the children\u2019s guardian and other individuals in the family tree for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors declared any confict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}